Kliniske studier for Astma i Colorado
18 studier for Astma søker deltakere på steder i Colorado.
Byer i Colorado
Offisiell studietekst (engelsk)
A Study to Compare the Efficacy, Safety and Tolerability of FF/UMEC/VI With FF/VI in 12-17-year-olds With Asthma
- GSK Investigational Site, Colorado Springs
RekruttererFase 3
Alder 12 til 17 · Alle kjønn · Oppdatert 30. sep. 2026 · NCT05757102ENV-294 for Moderate-to-Severe Asthma: A 12-Week Study in Adults
- Enveda Investigative Site, Colorado Springs
RekruttererFase 2
Alder 18 til 75 · Alle kjønn · Oppdatert 24. sep. 2026 · NCT07301255Roll-over Study for Participants Who Have Completed a Previous Clinical Study With Benralizumab (Fasenra) and Benefit From Continued Treatment
- Research Site, Aurora
RekruttererFase 3
Alder 6 og eldre · Alle kjønn · Oppdatert 22. sep. 2026 · NCT07444567A Study to Evaluate Brenipatide Compared With Placebo in Adult Participants With Uncontrolled Moderate to Severe Asthma
- Asthma & Allergy Associates - Colorado Springs, Colorado Springs
RekruttererFase 2
Alder 18 til 75 · Alle kjønn · Oppdatert 22. sep. 2026 · NCT07219173A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate-To-Severe Asthma
- Colorado ENT & Allergy, Colorado Springs
RekruttererFase 2
Alder 18 til 70 · Alle kjønn · Oppdatert 22. sep. 2026 · NCT06977581A Study to Investigate GB-0895 Adjunctive Therapy in Adults and Adolescents With Severe Uncontrolled Asthma (SOLAIRIA-1)
- Research Site 15, Colorado Springs
RekruttererFase 3
Alder 12 til 80 · Alle kjønn · Oppdatert 21. sep. 2026 · NCT07276724PULmonary Stimulation for Asthma Relief
- National Jewish Health, Denver
Rekrutterer
Alder 18 til 75 · Alle kjønn · Oppdatert 16. sep. 2026 · NCT07709754A Randomized, Double-Blind, Placebo-Controlled Trial on Efficacy and Safety of Fluticasone Propionate/Albuterol Sulfate Combination in Participants 12 Years and Older With Asthma
- Teva Investigational Site 12142, Lakewood
RekruttererFase 3
Alder 12 og eldre · Alle kjønn · Oppdatert 31. aug. 2026 · NCT06664619A Study of Depemokimab in Participants of 6 to 11 Years of Age
- GSK Investigational Site, Colorado Springs
RekruttererFase 3
Alder 6 til 11 · Alle kjønn · Oppdatert 26. aug. 2026 · NCT07671001Registry of Asthma Characterization and Recruitment 3 (RACR3)
- Children's Hospital Colorado: Allergy Program, Aurora
RekruttererObservasjonsstudieFrivillige helsepersonell ønskes velkommen
Alle aldre · Alle kjønn · Oppdatert 21. aug. 2026 · NCT05272241A Study of Efficacy and Safety of Depemokimab Compared With Placebo in Adults and Adolescents With at Risk Type 2 Asthma
- GSK Investigational Site, Aurora
RekruttererFase 3
Alder 12 og eldre · Alle kjønn · Oppdatert 17. aug. 2026 · NCT07456033Evaluating the Efficacy and Safety of PT027 Compared With PT007 Administered As Needed in Participants 12 to < 18 Years of Age With Asthma
- Research Site, Denver
RekruttererFase 3
Alder 12 til 17 · Alle kjønn · Oppdatert 13. aug. 2026 · NCT06307665Protocol CAUSE-03 / CHEETAH
- Children's Hospital Colorado: Allergy Program, Aurora
RekruttererObservasjonsstudieFrivillige helsepersonell ønskes velkommen
Alder 6 til 17 · Alle kjønn · Oppdatert 1. jul. 2026 · NCT06136091Individualizing Treatment for Asthma in Primary Care (Full Study)
- DARTNet Institute, Aurora
- University Colorado-Denver, Aurora
RekruttererFase 4
Alder 13 til 75 · Alle kjønn · Oppdatert 29. okt. 2025 · NCT07052942Anti Inflammatory Lipid Mediators in Asthma Lipid Anti-Inflammtory Mediators in Asthma
- University of Colorado Anschutz Medical Campus, Aurora
RekruttererFase 2
Alder 18 til 65 · Alle kjønn · Oppdatert 10. jun. 2025 · NCT03762395Study to Improve Deployment Related Asthma by Using L-Citrulline Supplementation
- National Jewish Health, Denver
RekruttererFase 2
Alder 18 til 70 · Alle kjønn · Oppdatert 6. apr. 2023 · NCT05259904Obesity, Metabolic Dysregulation and the Airway Epithelium in Asthmatics
- University of Colorado, Aurora
Rekrutterer
Alder 18 til 65 · Alle kjønn · Oppdatert 2. feb. 2023 · NCT03215836Reslizumab in the Treatment of Eosinophilic Granulomatosis With Polyangiitis (EGPA) Study
- National Jewish Health, Denver
RekruttererFase 2
Alder 18 og eldre · Alle kjønn · Oppdatert 14. sep. 2017 · NCT02947945Fra ClinicalTrials.gov, data hentet 4. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.